Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Meta Platforms, AMD Lead 10 Stocks Showing This Bullish Action

Meta Platforms and AMD are among several leading stocks finding support around the 10-week line, creating potential buying opportunities.

Investors Business Daily

Ozempic, weight-loss drugs force a change of focus on health

Ozempic, weight-loss drugs force a change of focus on health

The effectiveness of weight-loss drugs mean people who take them have more fitness challenges to confront.

Study: ‘gamechanger’ diabetes drugs cost up to 400 times more than needed

Study: ‘gamechanger’ diabetes drugs cost up to 400 times more than needed

Drug companies urged to ‘release stranglehold’ on medicines such as Ozempic and Trulicity, as millions are priced out of treatment

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback

The Alzheimer's treatment space is heating up — and could soon leave Eli Lilly's embattled drug, donanemab, in the dust, experts say.

Investors Business Daily

Dow Jones Futures: Small Caps Jump As Nvidia, Growth Leaders Skid

Small caps lead the stock market's broad advance Wednesday, but Nvidia and other growth leaders retreated.

Investors Business Daily

IBD Stock Of The Day Eli Lilly Jumps Early Entry As Viking Charges Obesity Space

Eli Lilly stock is Wednesday's IBD Stock Of The Day. Shares are forming a flat base as competition mounts for its weight-loss drug, Zepbound.

Investors Business Daily

Viking Surges After Weight-Loss Pill — A Rival To Novo, Lilly — Beats Expectations In Just 28 Days

Viking stock gapped up Tuesday after the biotech company's oral weight-loss drug beat expectations in a 28-day study.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Alzheimer’s ‘breakthrough’ stalls: why a much-hyped drug is facing approval delays

Alzheimer’s ‘breakthrough’ stalls: why a much-hyped drug is facing approval delays

The benefits of drugs such as donanemab, aducanumab and lecanemab are proving harder to quantify than potential harms, experts say

The Guardian - AU

Dow Jones Futures Fall: Fed, AI Boom Keep Driving Market; 3 Stocks Near Buy Points

Dow Jones Futures Fall: Fed, AI Boom Keep Driving Market; 3 Stocks Near Buy Points

The dovish Fed and the Nvidia-led AI boom continue to be the big stock market catalysts. Uber and Eli Llly are setting up in messy bases.

Investors Business Daily

Medicare Will Cover Weight-Loss Drugs — For Some. Here's What It Means For Novo, Lilly.

Medicare Will Cover Weight-Loss Drugs — For Some. Here's What It Means For Novo, Lilly.

Novo Nordisk and Eli Lilly stocks dipped Thursday after Medicare said it could pay for weight-loss drugs for some members.

Investors Business Daily

Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss

Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss

Eli Lilly's Mounjaro and Novo Nordisk's Ozempic and Wegovy are headliners in the expected boom in GLP-1 weight-loss drugs. But investors are making even more money on tangential players.

Investors Business Daily

Analyst revamps Eli Lilly stock price target on weight loss drug

Analyst revamps Eli Lilly stock price target on weight loss drug

Here's what could happen to Eli Lilly shares next.

Eli Lilly Taps Amazon's Pharmacy To Deliver Meds, Including Weight-Loss Drug Zepbound

Eli Lilly Taps Amazon's Pharmacy To Deliver Meds, Including Weight-Loss Drug Zepbound

Eli Lilly said Wednesday it tapped Amazon.com's pharmacy division to deliver some of its prescription meds, including its weight-loss drug.

Investors Business Daily

Stocks Give Up Early Gains and Close Lower as Chip Stocks Retreat

Stocks Give Up Early Gains and Close Lower as Chip Stocks Retreat

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.18% and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.53%. Stock indexes on Friday gave up early gains and closed moderately lower. Stocks on...

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Novo Nordisk Wins FDA Approval For Obesity Drug, Wegovy, To Cut Cardiovascular Risk

Novo Nordisk said Friday its weight-loss drug gained FDA approval to cut the risk of heart attack and strokes. Novo Nordisk stock dipped.

Stocks Slide After U.S. Unemployment Report

The S&P 500 Index ($SPX ) (SPY ) is down -0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. Stock indexes are lower this afternoon, after the S&P 500 and Nasdaq 100 posted new...

After a Morning Rally, Stocks Slide This Afternoon After Digesting the U.S. Unemployment Report

The S&P 500 Index ($SPX ) (SPY ) is down -0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. Stock indexes are lower this afternoon, after the S&P 500 and Nasdaq 100 posted new...

S&P 500 and Nasdaq 100 Post Record Highs on Fed-Friendly U.S. Unemployment Report

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.45%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.27%. Stock indexes this morning are moderately higher, with the S&P 500 and Nasdaq...

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Rally Hits Fresh Highs As Nvidia, Novo Nordisk, Bitcoin Soar: Weekly Review

The Nasdaq and S&P 500 hit fresh all-time highs, with Nvidia and bitcoin continuing to surge.

Stocks Gain as U.S. Unemployment Report Bolsters the Outlook for Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.29%. Stock indexes this morning are moderately higher, with the S&P 500 and Nasdaq...

International Business Times

Highly Awaited Alzheimer's Drug Hit By Delays

Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.

Investors Business Daily

Biogen Surges On A Setback For Eli Lilly's Rival Alzheimer's Treatment

Biogen stock jumped Friday after the FDA delayed its approval decision on Eli Lilly's rival Alzheimer's treatment, donanemab.

Stocks Climb on Lower U.S. and European Bond Yields

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.61%. Stock indexes this morning are seeing support from a decline in the 10-year...

Investors Business Daily

Novo Nordisk Shoots To Record High After New Pill Tops Weight-Loss Blockbuster Wegovy

Novo Nordisk rose to a record high after the drugmaker said its experimental oral weight-loss drug outperformed Wegovy in an early-stage study.

Investors Business Daily

Dow Jones Futures Fall: Taiwan Semi, 7 Leaders Offer New Chance; Super Micro Soars On S&P 500 News

The Nasdaq hit a record high, but is again extended. Taiwan Semi was among leaders offering new entries. Super Micro soared on S&P 500 news.

1 … 9 10 11 12

People

Todd Rosenbluth

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Alzheimer Disease

Places

243,972 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play